Expression, prognostic and predictive impact of VEGF and bFGF in non-small cell lung cancer

被引：60
|
作者：
Farhat, Fadi S. [2 ]
Tfayli, Arafat [3 ]
Fakhruddin, Najla [5 ]
Mahfouz, Rami [4 ]
Otrock, Zaher K. [3 ]
Alameddine, Raafat S. [3 ,6 ]
Awada, Ahmad H. [1 ]
Shamseddine, Ali [3 ,7 ]
机构：
[1] Univ Libre Bruxelles, Inst Jules Bordet, Med Oncol Clin, B-1000 Brussels, Belgium
[2] Hammoud Hosp Univ Med Ctr, Dept Hematol Oncol, Saida, Lebanon
[3] Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut, Lebanon
[4] Amer Univ Beirut, Med Ctr, Dept Pathol & Lab Med, Fac Med, Beirut, Lebanon
[5] Hammoud Hosp Univ Med Ctr, Dept Pathol, Saida, Lebanon
[6] Amer Univ Beirut, Nayef K Basil Canc Ctr, Beirut, Lebanon
[7] Amer Univ Beirut, Div Hematol Oncol, Beirut, Lebanon
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2012年 / 84卷 / 02期
关键词：
Non-small cell lung cancer; VEGF; bFGF; Angiogenic markers; Expression; Prognostic impact; Review; ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; FACTOR MESSENGER-RNA; RANDOMIZED PHASE-II; INCREASED SERUM-LEVELS; TUMOR ANGIOGENESIS; FACTOR-C; CLINICAL-SIGNIFICANCE; LYMPHATIC VESSELS; FACTOR FAMILY;
D O I：
10.1016/j.critrevonc.2012.02.012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Despite major advances in cancer therapeutics, the prognosis for lung cancer patients is still poor and the median survival for patients presenting with advanced non-small cell lung cancer (NSCLC) is only 8-10 months. Angiogenesis is an important biological process and a relatively early event during lung cancer pathogenesis. Anti-angiogenic agents are used in treating patients with NSCLC, and their molecular biomarkers are also being assessed to predict response. A better understanding of the biology of angiogenesis in NSCLC may reveal new targets for treating this malignancy. In this article, we review the expression and prognostic impact of the angiogenic growth factors, vascular endothelial growth factor and basic fibroblast growth factor, in NSCLC. (C) 2012 Published by Elsevier Ireland Ltd.
引用
收藏
页码：149 / 160
页数：12
相关论文
共 50 条
  • [41] Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer
    Xie, Mian
    Zhang, Li
    He, Chao-Sheng
    Hou, Jin-Hui
    Lin, Su-Xia
    Hu, Zhi-Huang
    Xu, Fei
    Zhao, Hong-Yun
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (05) : 799 - 807
  • [42] Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer
    Kimura, Madoka
    Naito, Tateaki
    Kenmotsu, Hirotsugu
    Taira, Tetsuhiko
    Wakuda, Kazushige
    Oyakawa, Takuya
    Hisamatsu, Yasushi
    Tokito, Takaaki
    Imai, Hisao
    Akamatsu, Hiroaki
    Ono, Akira
    Kaira, Kyoichi
    Murakami, Haruyasu
    Endo, Masahiro
    Mori, Keita
    Takahashi, Toshiaki
    Yamamoto, Nobuyuki
    SUPPORTIVE CARE IN CANCER, 2015, 23 (06) : 1699 - 1708
  • [43] Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer
    Madoka Kimura
    Tateaki Naito
    Hirotsugu Kenmotsu
    Tetsuhiko Taira
    Kazushige Wakuda
    Takuya Oyakawa
    Yasushi Hisamatsu
    Takaaki Tokito
    Hisao Imai
    Hiroaki Akamatsu
    Akira Ono
    Kyoichi Kaira
    Haruyasu Murakami
    Masahiro Endo
    Keita Mori
    Toshiaki Takahashi
    Nobuyuki Yamamoto
    Supportive Care in Cancer, 2015, 23 : 1699 - 1708
  • [44] Prognostic significance of dysadherin expression in patients with non-small cell lung cancer
    Tamura, M
    Ohta, Y
    Tsunezuka, Y
    Matsumoto, I
    Kawakami, K
    Oda, M
    Watanabe, G
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 130 (03): : 740 - 745
  • [45] Prognostic significance of annexin II expression in non-small cell lung cancer
    C.-H. Luo
    Q.-Q. Liu
    P.-F. Zhang
    M.-Y. Li
    Z.-C. Chen
    Y.-F. Liu
    Clinical and Translational Oncology, 2013, 15 : 938 - 946
  • [46] MASPIN EXPRESSION IS A FAVOURABLE PROGNOSTIC FACTOR IN NON-SMALL CELL LUNG CANCER
    Berardi, R.
    Santinelli, A.
    Onofri, A.
    Brunelli, A.
    Pierantoni, C.
    Mazzanti, P.
    Sabbatini, A.
    Bearzi, I.
    Cascinu, S.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S38 - S38
  • [47] The prognostic value of 4.1 mRNA expression in non-small cell lung cancer
    Xiang, Yuying
    Shan, Feiyu
    Feng, Guan
    Guo, Kaibo
    Ruan, Shanming
    Huang, Dawei
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (03) : 1216 - 1228
  • [48] Prognostic significance of annexin II expression in non-small cell lung cancer
    Luo, C. -H.
    Liu, Q. -Q.
    Zhang, P. -F.
    Li, M. -Y.
    Chen, Z. -C.
    Liu, Y. -F.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (11): : 938 - 946
  • [49] Prognostic Significance of Stromal Periostin Expression in Non-Small Cell Lung Cancer
    Ratajczak-Wielgomas, Katarzyna
    Kmiecik, Alicja
    Grzegrzolka, Jedrzej
    Piotrowska, Aleksandra
    Gomulkiewicz, Agnieszka
    Partynska, Aleksandra
    Pawelczyk, Konrad
    Nowinska, Katarzyna
    Podhorska-Okolow, Marzenna
    Dziegiel, Piotr
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (19) : 1 - 18
  • [50] Maspin Expression Is a Favorable Prognostic Factor in Non-Small Cell Lung Cancer
    Berardi, Rossana
    Santinelli, Alfredo
    Onofri, Azzurra
    Brunelli, Alessandro
    Pierantoni, Chiara
    Pisa, Eleonora
    Pagliacci, Alessandra
    Stramazzotti, Daniela
    Zuccatosta, Lina
    Mazzanti, Paola
    Sabbatini, Armando
    Gasparini, Stefano
    Bearzi, Italo
    Cascinu, Stefano
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2012, 34 (02): : 72 - 78
12345